Big Data IV: breakthroughs in drug discovery with AI

Synopsis

Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge. A system that suggests actions to a user is one definition of Artificial Intelligence (AI). These approaches have thrown up surprising, often counter-intuitive results, and led to much wider uptake of AI technologies. Since the last meeting in February 2024, much has happened in chemical industries with whole companies spawned around the use of AI to achieve breakthroughs. The pharmaceutical industry has two big problems i) well validated biological targets and ii) quality chemical start matter (hits) to optimise into drugs. In the fourth event in this series, the presenters will update on what is working for chemistry to address these two issues and what is not.

---

Attendees

This conference is intended to be a high-level overview of the state of the art in the field for chemists interested in learning more, and for decision makers who want an update on what is going on (as opposed to an in-depth conference by and for technical specialists). The previous meetings attracted a well-informed audience that was open to discussion and debate.  This event will be of interest to a wide range of scientific disciplines including project leaders, VPs and Directors of Medicinal, Agrochemical, Materials and Computational Chemistry. Technical experts in the field who want a broad update and to contribute to a vibrant meeting and discussion are also welcome.

---

Confirmed speakers

Kathryn Giblin, AstraZeneca
Ed Griffen, MedChemica Ltd and OpenBind Consortium
Tudor Oprea, Drug Hunter
Robin Roehm, Apheris
Geoffrey Smith, Boltz

---

Programme

The full programme will be confirmed in due course.

---

Sponsorship and exhibition information

Please see the sponsorship pack and email conferences@soci.org to let us know which package you are interested in.

---

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

---

Venue and Contact

---

Booking Process/Deadlines

Booking terms and conditions

---

CPD Info

All delegates attending this meeting are able to claim CPD points.

---

Organising committee

Stephen Atkinson, AstraZeneca
Al Dossetter, MedChemica Limited
Antonio Misale, J & J
Pascal Savy, Isomorphic Labs
Jason Tierney, Top Tier Consultancy

---